These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7398760)

  • 1. GABA inhibition of 3H-glycine release from slices of rat substantia nigra in vitro.
    Kerwin R; Pycock C
    Eur J Pharmacol; 1980 Jun; 64(2-3):169-72. PubMed ID: 7398760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific stimulating effect of glycine on 3H-dopamine efflux from substantia nigra slices of the rat.
    Kerwin RW; Pycock CJ
    Eur J Pharmacol; 1979 Feb; 54(1-2):93-8. PubMed ID: 421746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic GABA autoreceptors on GABAergic nerve endings of the rat substantia nigra.
    Arbilla S; Kamal L; Langer SZ
    Eur J Pharmacol; 1979 Aug; 57(2-3):211-7. PubMed ID: 226375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
    Arbilla S; Kamal LA; Langer SZ
    Br J Pharmacol; 1981 Oct; 74(2):389-97. PubMed ID: 7317688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P release from the rat substantia nigra.
    Jessell TM
    Brain Res; 1978 Aug; 151(3):469-78. PubMed ID: 667625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of GABA, L-glutamic acid and nicotine on the potassium-evoked release of substance P in substantia nigra slices of the rat.
    Torrens Y; Beaujouan JC; Besson MJ; Michelot R; Glowinski J
    Eur J Pharmacol; 1981 May; 71(4):383-92. PubMed ID: 6166487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
    Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
    Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous and potassium-evoked release of 3H-GABA newly synthesized from 3H-glutamine in slices of the rat substantia nigra.
    Kemel ML; Gauchy C; Glowinski J; Besson MJ
    Life Sci; 1979 Jun; 24(23):2139-49. PubMed ID: 481104
    [No Abstract]   [Full Text] [Related]  

  • 9. GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum.
    Starr MS
    Eur J Pharmacol; 1978 Apr; 48(3):325-8. PubMed ID: 639860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of GABA as a stimulator of dopamine release in rat substantia nigra.
    Starr MS
    Neurosci Lett; 1980 May; 18(1):79-84. PubMed ID: 6133247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of dopamine and dopamine agonists on the release of 3H-GABA and 3H-5HT from rat nigral slices.
    Kelly E; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 Aug; 34(15):2655-62. PubMed ID: 3925957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of gamma-[3H]aminobutyric acid from rat olfactory bulb and substantia nigra: differential modulation by glutamic acid.
    Jaffé EH; Vaello ML
    J Neurochem; 1989 Jun; 52(6):1766-74. PubMed ID: 2566648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory action of taurine on the release of GABA in cerebellar slices of the guinea pig.
    Namima M; Okamoto K; Sakai Y
    J Neurochem; 1983 Jan; 40(1):1-9. PubMed ID: 6129286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro inhibition of GABA release by tetanus toxin.
    Collingridge GL; Davies J
    Neuropharmacology; 1982 Sep; 21(9):851-5. PubMed ID: 7145039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of GABA, dopamine, and substance P on the release of newly synthesized 3H-5-hydroxytryptamine from rat substantia nigra in vitro.
    Reubi JC; Emson PC; Jessell TM; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 304(3):271-5. PubMed ID: 714184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic modulation of the release of GABA by GABAA receptors in pars compacta and by GABAB receptors in pars reticulata of the rat substantia nigra.
    Floran B; Silva I; Nava C; Aceves J
    Eur J Pharmacol; 1988 Jun; 150(3):277-86. PubMed ID: 2843383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of GABA-mediated inhibition of the electrically and potassium chloride evoked [3H]-GABA release from rat substantia nigra slices by DL-3-hydroxy-3-phenyl pentanamide.
    Meza-Toledo SE; Bowery NG
    Arzneimittelforschung; 2008; 58(2):53-61. PubMed ID: 18412018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-aminobutyric acid enhancement of potassium-stimulated release of [3H]norepinephrine by multiple mechanisms in rat cortical slices.
    Peoples RW; Giridhar J; Isom GE
    Biochem Pharmacol; 1991 Jan; 41(1):119-23. PubMed ID: 1986736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA terminal autoreceptors in the pars compacta and in the pars reticulata of the rat substantia nigra are GABAB.
    Giralt MT; Bonanno G; Raiteri M
    Eur J Pharmacol; 1990 Jan; 175(2):137-44. PubMed ID: 2155793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dendritic dopamine of the substantia nigra in the modulation of nigrocollicular gamma-aminobutyric acid release: in vivo studies in the rat.
    Lantin Le Boulch N; Truong-Ngoc NA; Gauchy C
    J Neurochem; 1991 Sep; 57(3):1080-3. PubMed ID: 1677673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.